Table 2 |
||||||
|
Odds ratios for co-prescription of anti-diabetes agents and mood stabilizers. |
||||||
|
Total |
||||||
|
|
||||||
|
Male |
Female |
|||||
|
|
||||||
|
Drugs |
OR |
CI (95%) |
OR |
CI (95%) |
OR |
Cl (95%) |
|
|
||||||
|
Lamotrigine and insulin |
1.8 |
(1.3, 2.5) |
1.8 |
(1.3, 2.4) |
1.7 |
(1.3, 2.1) |
|
Carbamazepine and insulin |
2.0 |
(1.3, 3.2) |
3.0 |
(1.9, 4.8) |
2.4 |
(1.8, 3.4) |
|
Lithium and insulin |
1.4 |
(1.0, 1.9) |
1.6 |
(1.1, 2.2) |
1.4 |
(1.1, 1.8) |
|
Valproate and insulin |
1.6 |
(1.1, 2.3) |
2.6 |
(1.8, 3.7) |
2.0 |
(1.5, 2.6) |
|
|
||||||
|
Lamotrigine and oral antidiabetics |
1.3 |
(1.0, 1.7) |
1.8 |
(1.5, 2.3) |
1.6 |
(1.3, 1.9) |
|
Carbamazepine and oral antidiabetics |
1.8 |
(1.3, 2.5) |
2.6 |
(1.8, 3.6) |
2.1 |
(1.7, 2.7) |
|
Lithium and oral antidiabetics |
1.5 |
(1.2, 1.8) |
2.6 |
(2.2, 3.0) |
1.9 |
(1.7, 2.2) |
|
Valproate and oral antidiabetics |
2.4 |
(1.9, 3.0) |
3.0 |
(2.3, 3.7) |
2.6 |
(2.2, 3.1) |
|
|
||||||
|
Odds ratios, with 95% CI, for using different mood stabilizers, combined or in in monotherapy for persons using anti-diabetes agents in monotherapy compared to the non diabetic population (divided into genders). |
||||||
|
Svendal et al. BMC Medicine 2012 10:148 doi:10.1186/1741-7015-10-148 |
||||||